TP53 and cancer: Additionally, under the tumor necrosis factor-alpha-induced (TNF-α-induced) chronic inflammatory environment, the mutant p53 reshapes the enhancer landscape by interacting with nuclear factor-κB (NF-κB), thereby promoting cancer progression [126].